Meeting
2023 ASCO Annual Meeting
Immune landscape of patients with metastatic non-clear cell renal cell carcinoma (nccRCC) treated with atezolizumab plus bevacizumab.
Authors
Renee Maria Saliby
Dana-Farber Cancer Institute, Boston, MA
Renee Maria Saliby , Talal El Zarif , Ziad Bakouny , Wanling Xie , Ronan Flippot , Thomas Denize , Valisha Shah , Harry Kane , Katrine Madsen , Lauren C Harshman , Ulka N. Vaishampayan , David F. McDermott , Gwo-Shu Mary Lee , Wenxin Xu , Eliezer Mendel Van Allen , Bradley Alexander McGregor , Sabina Signoretti , Toni K. Choueiri , Rana R. McKay , David A. Braun
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Kidney and Bladder
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4535)
DOI
10.1200/JCO.2023.41.16_suppl.4535
Abstract #
4535
Poster Bd #
27
Abstract Disclosures
Similar Posters
Poster
2020 Genitourinary Cancers Symposium
Circulating immune cell populations and cytokines in patients with metastatic variant histology renal cell carcinoma (vRCC) treated with atezolizumab plus bevacizumab (AB): Dynamic changes on therapy and association with outcomes from a phase II trial.
First Author: Ronan Flippot
Poster
2018 Gastrointestinal Cancers Symposium
Mice with targeted KrasG12D and loss of p53 in the liver: A robust model for studying immunologic interventions for treating cholangiocarcinoma
First Author: Booyeon Julia Han
Poster
2013 ASCO Annual Meeting
Immunomodulatory effects of a dipeptidyl peptidase inhibitor, ARI-4175, and NK cell activation in a colon cancer model.
First Author: Alexander Macfarlane III
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Ex vivo oncolytic and immune activity of CF33-hNIS-antiPDL1 against fresh peritoneal cells from patients with gastric cancer with and without peritoneal metastases.
First Author: Zhifang Zhang